Literature DB >> 16647070

Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells.

Ruth E Freeman1, Jiri Neuzil.   

Abstract

Malignant mesothelioma (MM) is a fatal type of cancer. We studied the role of the redox-active protein thioredoxin-1 (Trx-1) in apoptosis induced in MM cells and their non-malignant counterparts (Met-5A) by alpha-tocopheryl succinate (alpha-TOS) and TNF-related apoptosis-inducing ligand (TRAIL). MM cells were susceptible to alpha-TOS and less to TRAIL, while Met-5A cells were susceptible to TRAIL and resistant to alpha-TOS. MM cells expressed very low level of the Trx-1 protein, which was high in Met-5A cells, while the level of Trx-1 mRNA was similar in all cell lines. Downregulation of Trx-1 further sensitised Met-5A cells to TRAIL but not to alpha-TOS. Our data suggest that the role of Trx-1 in apoptosis modulation is unrelated to its anti-oxidant properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647070     DOI: 10.1016/j.febslet.2006.04.019

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  Thioredoxin in cancer--role of histone deacetylase inhibitors.

Authors:  Paul A Marks
Journal:  Semin Cancer Biol       Date:  2006-09-26       Impact factor: 15.707

2.  Regulation of thioredoxin by ceramide in retinal pigment epithelial cells.

Authors:  Parameswaran G Sreekumar; Yi Ding; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

3.  TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame.

Authors:  Ammad Ahmad Farooqi; Shahzad Bhatti; Muhammad Ismail
Journal:  Cancer Cell Int       Date:  2012-06-06       Impact factor: 5.722

Review 4.  Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II.

Authors:  Jiri Neuzil; Jeffrey C Dyason; Ruth Freeman; Lan-Feng Dong; Lubomir Prochazka; Xiu-Fang Wang; Immo Scheffler; Stephen J Ralph
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

5.  Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.

Authors:  Larisa L Belyanskaya; Thomas M Marti; Sally Hopkins-Donaldson; Stefanie Kurtz; Emanuela Felley-Bosco; Rolf A Stahel
Journal:  Mol Cancer       Date:  2007-10-22       Impact factor: 27.401

6.  PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-kappaB-dependent proinflammatory activation of alveolar epithelial cells.

Authors:  M E Callister; L Pinhu; M C Catley; A D Westwell; R Newton; S K Leaver; G J Quinlan; T W Evans; M J Griffiths; A Burke-Gaffney
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.